GY025 Randomized Phase II Trial Of Nivolumab And Ipilimumab Compared To Nivolumab Monotherapy In Patients With Deficient Mismatch Repair System Recurrent Endometrial Carcinoma



Mary Beth Wilwerding, RN Admin@NEcancertrials.com



Available at Nebraska Methodist Estabrook Cancer Center

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*

Email*

Phone*

Message*